Health impact and cost-effectiveness analysis of gender-neutral versus female-only 9-valent human papillomavirus vaccination in Taiwan. Chou HH, Chu PY, Wu YH, Feng C, et al. PLoS One 2025;20:e0333757.

Read + Share

Amedeo Smart

Independent Medical Education

Read + Share

Chou HH, Chu PY, Wu YH, Feng C, et al. Health impact and cost-effectiveness analysis of gender-neutral versus female-only 9-valent human papillomavirus vaccination in Taiwan. PLoS One 2025;20:e0333757.
PMID: 41086167